FAP and neoplasm: Based on single-cell analysis revealing RNF157's heterogeneous expression in cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs), we performed validation experiments using lentiviral shRNAs targeting FAP in CAFs and CD11b in TAMs.